跳至主要内容
临床试验/CTRI/2023/06/053786
CTRI/2023/06/053786尚未招募不适用

A Comparative Clinical study on Erandathi Kwatha with Vaitarana vasti & Modern treatment regime in the management of Amavata(Rheumatoid arthritis) with special reference to Gut microbiota

Department of Kayachikitsa Faculty of Ayurveda IMS BHU1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年1月7日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
Sandhisotha

研究概览

简要总结

Rheumatoid arthritis is the most common chronic, immune -inflammatory systemic disease. In india the prevalence of RA is 0.65% -0.75% according to API. Although the etiology and pathogenesis of RA is not clear but its presumed that autoimmunity plays a significant role in the genesis of disease, Chronicity and progression of RA. The conventional medical management is always challenged by the poor response, adverse effects, invasive complications. in this study, will evaluate the importance of anti-rheumatic drug induced host microbiota modulations and possible probiotics that can generate eubiosis. The present clinical study aim to assess clinically the efficacy of Erandathi Kwatha with Vaitharana vasti and Modern treatment regime in the management of Amavata(RA) with special reference to Gut microbiota. There will be 3 month duration with monthly follow up with medication. Assessment will be done on the basis of prepared proforma for subjective and objective parameters.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients aged between 16 – 60 years age.
  • 2.Diagnosed cases of Amavata/RA based on symptoms and signs described in Madava Nidana & ACR 2010 3.Patients with H/O more than 1 year with established disease.
  • 4.Sero positive and sero negative both cases are included.

排除标准

  • 1.Patients below the age of 16 and above 60 years of age 2.Patients suffering from systemic disorders (like Diabetes Mellitus, Cardiac diseases, Pulmonary Tuberculosis, Essential Hypertension, SLE, Infectious Arthritis, Hypertrophic Arthropathy) 3.Pregnant & Lactating women.

结局指标

主要结局

Sandhisotha

时间窗: Three months with monthly follow up

Relief in Sandhisoola

时间窗: Three months with monthly follow up

Sandhigraha

时间窗: Three months with monthly follow up

Sparsahatwa & Jwara

时间窗: Three months with monthly follow up

次要结局

  • Assessment of-(1 Laboratory parameters)

研究者

发起方
Department of Kayachikitsa Faculty of Ayurveda IMS BHU
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验